Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06951659

Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours

Led by The University of Western Australia · Updated on 2025-06-19

100

Participants Needed

1

Research Sites

28 weeks

Total Duration

On this page

Sponsors

T

The University of Western Australia

Lead Sponsor

S

Sir Charles Gairdner Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neuroimaging analysis, of a neurosurgical cohort of patients with brain tumours. This prospective observational cohort study will investigate clinical and neuroimaging characteristics and the relationship between lateropulsion and visual verticality disorder in patients pre- and post-brain tumour resection. Patients (aged 18-80 years, with a confirmed diagnosis of brain tumour and a neurosurgical pathway) will be enrolled from the state-wide Neurosurgery Service of Western Australia at Sir Charles Gairdner Hospital.

CONDITIONS

Official Title

Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18 to 80 admitted to SCGH under the neurosurgery team with confirmed brain tumour diagnosis
  • Undergoing partial or full brain tumour resection and medically stable
  • Able to provide written informed consent or have consent provided by a Research Decision-Maker with Independent Medical Practitioner approval
  • Have a support network to assist with travel for assessments if required
Not Eligible

You will not qualify if you...

  • Undergoing only biopsy without tumour resection
  • Unable to follow instructions or complete assessments due to significant medical deterioration
  • Pregnant
  • Current diagnosis of COVID-19, respiratory syncytial virus (RSV), or any type of influenza
  • Lack a support network to assist with travel for assessments if required
  • Have an Advanced Care Health Directive preventing decision making by a Research Decision-Maker

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sir Charles Gairdner Osborne Park Health Care Group

Perth, Western Australia, Australia, 6009

Actively Recruiting

Loading map...

Research Team

J

Jimena Garcia-Vega, MSc

CONTACT

A

Anne-Marie Hill, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here